Philip H. Coelho

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Rancho Cordova, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Philip H. Coelho
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Philip H. Coelho

Form 4 holding Director

CATALYST PHARMACEUTICALS, INC.

Security class
Common stock, par value $0.001 per share
Shares / value
204,887
Estimated value
$231,522
Report date
04 May 2023
Price
$1.13
Ownership
Direct
Form 4 holding Director

CATALYST PHARMACEUTICALS, INC.

Security class
Options to purchase Common Stock
Shares / value
260,500
Estimated value
Report date
04 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Ampio Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
75,000
Estimated value
Report date
30 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Philip H. Coelho

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .